These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14502491)

  • 1. QSAR analysis of SH2-binding phosphopeptides: using interaction energies and cross-correlation coefficients.
    Moon T; Song JS; Lee JK; Yoon CN
    J Chem Inf Comput Sci; 2003; 43(5):1570-5. PubMed ID: 14502491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of phosphopeptide binding to SH2 domain.
    Lee JK; Moon T; Chi MW; Song JS; Choi YS; Yoon CN
    Biochem Biophys Res Commun; 2003 Jun; 306(1):225-30. PubMed ID: 12788092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New descriptors of amino acids and their application to peptide QSAR study.
    Lin ZH; Long HX; Bo Z; Wang YQ; Wu YZ
    Peptides; 2008 Oct; 29(10):1798-805. PubMed ID: 18606203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthetic Src SH2 domains demonstrate altered phosphopeptide specificity induced by incorporation of unnatural lysine derivatives.
    Virdee S; Macmillan D; Waksman G
    Chem Biol; 2010 Mar; 17(3):274-84. PubMed ID: 20338519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of water in computational and experimental derivation of binding thermodynamics in SH2 domains.
    Geroult S; Virdee S; Waksman G
    Chem Biol Drug Des; 2006 Jan; 67(1):38-45. PubMed ID: 16492147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying information transfer by protein domains: analysis of the Fyn SH2 domain structure.
    Lenaerts T; Ferkinghoff-Borg J; Stricher F; Serrano L; Schymkowitz JW; Rousseau F
    BMC Struct Biol; 2008 Oct; 8():43. PubMed ID: 18842137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
    Dolezal R; Van Damme S; Bultinck P; Waisser K
    Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives.
    de Armas RR; Díaz HG; Molina R; Uriarte E
    Biopolymers; 2005 Apr; 77(5):247-56. PubMed ID: 15682438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure activity relationship (QSAR) study of estrogen derivatives based on descriptors of energy and softness.
    Pasha FA; Neaz MM; Cho SJ; Kang SB
    Chem Biol Drug Des; 2007 Dec; 70(6):520-9. PubMed ID: 17999665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
    Murcia M; Morreale A; Ortiz AR
    J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Prusis P; Mutule I; Mutulis F; Wikberg JE
    J Med Chem; 2003 Jun; 46(13):2572-9. PubMed ID: 12801221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR study of imidazoline antihypertensive drugs.
    Nikolic K; Filipic S; Agbaba D
    Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.